Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-02

Clinical Trial Update: Surgery for Recurrent Glioblastoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing surgical treatment for recurrent glioblastoma is currently recruiting, sponsored by Insel Gruppe AG and University Hospital B…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Glioblastoma | Phase 2 | Status: RECRUITING